Acetylcholine, drug reward and substance use disorder treatment: Intra-and interindividual striatal and accumbal neuron ensemble heterogeneity may explain apparent discrepant findings

Pharmacology

Volumn 90, Issue 5-6, 2012, Pages 264-273

  Prast, Janine M ^a   Kummer, Kai K ^a   Barwitz, Constanze M ^a   Humpel, Christian ^b   Dechant, Georg ^c   Zernig, Gerald ^a  

^a Experimental Psychiatry Unit   (Austria)

^b Laboratory of Psychiatry and Experimental Alzheimer's Research   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Acetylcholine; Cholinergic Interneuron; Cocaine; Nucleus Accumbens; Social Interaction; Striatum; Substance use disorder; Zif268

Indexed keywords

ACETYLCHOLINE; UNCLASSIFIED DRUG; ZIF268 PROTEIN; ZINC FINGER PROTEIN;

ACCURACY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; CHOLINERGIC STIMULATION; COCAINE DEPENDENCE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DEPENDENCE TREATMENT; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INHIBITION (PSYCHOLOGY); INTERNEURON; MALE; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REVIEW; REWARD;

ACETYLCHOLINE; ANIMALS; BASAL GANGLIA; COCAINE; CONDITIONING (PSYCHOLOGY); EARLY GROWTH RESPONSE PROTEIN 1; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 84866699633     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000342636     Document Type: Review

References (48)

1. Grasing K, Yang Y, He S: Reversible and persistent decreases in cocaine self-administration after cholinesterase inhibition: different effects of donepezil and rivastigmine. Behav Pharmacol 2011;22:58-70.
2. Grasing K, He S, Yang Y: Dose-related effects of the acetylcholinesterase inhibitor tacrine on cocaine and food self-administration in rats. Psychopharmacology (Berl) 2008;196: 133-142.
3. Grasing K, He S, Yang Y: Long-lasting decreases in cocaine-reinforced behavior following treatment with the cholinesterase inhibitor tacrine in rats selectively bred for drug self-administration. Pharmacol Biochem Behav 2009;94:169-178.
4. Nielsen JA, Mena EE, Williams IH, Nocerini MR, Liston D: Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes. Eur J Pharmacol 1989;173:53-64. (Pubitemid 20006777)
5. Adem A, Jossan SS, Oreland L: Tetrahydroaminoacridine inhibits human and rat brain monoamine oxidase. Neurosci Lett 1989;107:313-317.
6. Williams MJ, Adinoff B: The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 2008;33:1779-1797. (Pubitemid 351832599)
7. Adinoff B, Devous MD Sr, Williams MJ, Best SE, Harris TS, Minhajuddin A, Zielinski T, Cullum M: Altered neural cholinergic receptor systems in cocaine-addicted subjects. Neuropsychopharmacology 2010;35:1485- 1499.
8. Mark GP, Shabani S, Dobbs LK, Hansen ST: Cholinergic modulation of mesolimbic dopamine function and reward. Physiol Behav 2011;104:76-81.
9. Hikida T, Kaneko S, Isobe T, Kitabatake Y, Watanabe D, Pastan I, Nakanishi S: Increased sensitivity to cocaine by cholinergic cell ablation in nucleus accumbens. Proc Natl Acad Sci USA 2001;98:13351-13354. (Pubitemid 33051366)
10. Hikida T, Kitabatake Y, Pastan I, Nakanishi S: Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci USA 2003;100:6169-6173. (Pubitemid 36576949)
11. Witten IB, Lin SC, Brodsky M, Diester I, Anikeeva P, Prakash R, Gradinaru V, Ramakrishnan C, Deisseroth K: Cholinergic interneurons control local circuit activity and cocaine conditioning. Science 2010;330:1677-1681.
12. Hiranita T, Nawata Y, Sakimura K, Anggadiredja K, Yamamoto T: Suppression of methamphetamine-seeking behavior by nicotinic agonists. Proc Natl Acad Sci USA 2006;103:8523-8527. (Pubitemid 43838488)
13. Thomsen M, Conn PJ, Lindsley C, Wess J, Boon JY, Fulton BS, Fink-Jensen A, Caine SB: Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation. J Pharmacol Exp Ther 2010;332:959-969.
14. Smith JE, Co C, Yin X, Sizemore GM, Liguori A, Johnson WE 3rd, Martin TJ: Involvement of cholinergic neuronal systems in intravenous cocaine self-administration. Neurosci Biobehav Rev 2004;27:841-850. (Pubitemid 38199614)
15. Zernig G, Ahmed SH, Cardinal RN, Morgan D, Acquas E, Foltin RW, Vezina P, Negus SS, Crespo JA, Sţkl P, Grubinger P, Madlung E, Haring C, Kurz M, Saria A: Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology 2007;80:65-119. (Pubitemid 47230704)
16. Wilson MC, Schuster CR: Cholinergic influence on intravenous cocaine self-administration by rhesus monkeys. Pharmacol Biochem Behav 1973;1:643-649.
17. Zernig G, Wakonigg G, Madlung E, Haring C, Saria A: Do vertical shifts in dose-response rate-relationships in operant conditioning procedures indicate 'sensitization' to 'drug wanting'? Psychopharmacology (Berl) 2004;171:349-351.
18. English DF, Ibanez-Sandoval O, Stark E, Tecuapetla F, Buzsaki G, Deisseroth K, Tepper JM, Koos T: GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons. Nat Neurosci 2011;15:123-130.
19. Mark GP, Hajnal A, Kinney AE, Keys AS: Self-administration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats. Psychopharmacology (Berl) 1999;143:47-53. (Pubitemid 29189994)
20. Acquas E, Wilson C, Fibiger HC: Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo. J Pharmacol Exp Ther 1997;281:360-368. (Pubitemid 27203089)
21. Acquas E, Marrocu P, Pisanu A, Cadoni C, Zernig G, Saria A, DiChiara G: Intravenous administration of 3,4-methylenedioxymethamphetamine ('ecstasy') enhances cortical and striatal acetylcholine in vivo. Eur J Pharmacol 2001;418:207-211. (Pubitemid 32441581)
22. Crespo JA, Sturm K, Saria A, Zernig G: Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcement. J Neurosci 2006;26:6004-6010. (Pubitemid 44318366)
23. Crespo JA, Sţkl P, Zorn K, Saria A, Zernig G: Nucleus accumbens core acetylcholine is preferentially activated during acquisition of drug- vs. Food-reinforced behavior. Neuropsychopharmacology 2008;33:3213-3220.
24. Crespo JA, Sţkl P, Ueberall F, Jenny M, Saria A, Zernig G: Activation of PKCzeta and PKMzeta in the nucleus accumbens core is necessary for the retrieval, consolidation and reconsolidation of drug memory. PLoS One 2012;7:e30502.
25. Itzhak Y, Martin JL: Scopolamine inhibits cocaine-conditioned but not unconditioned stimulant effects in mice. Psychopharmacology (Berl) 2000;152:216-223.
26. De La Garza R, Mahoney JJ 3rd, Culbertson C, Shoptaw S, Newton TF: The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. Pharmacol Biochem Behav 2008;89:200-208.
27. De La Garza R, Shoptaw S, Newton TF: Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetaminedependent human volunteers. Int J Neuropsychopharmacol 2008;11:729-741.
28. De La Garza R 2nd, Newton TF, Haile CN, Yoon JH, Nerumalla CS, Mahoney JJ 3rd, Aziziyeh A: Rivastigmine reduces 'likely to use methamphetamine' in methamphetaminedependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry 2012;37:141-146.
29. Grasing K, Mathur D, Newton TF, DeSouza C: Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals. Drug Alcohol Depend 2010;107:69-75.
30. Mann K, Ackermann K, Diehl A, Ebert D, Mundle G, Nakovics H, Reker T, Richter G, Schmidt LG, Driessen M, Rettig K, Opitz K, Croissant B: Galantamine: a cholinergic patch in the treatment of alcoholism: a randomized, placebo-controlled trial. Psychopharmacology (Berl) 2006;184:115-121. (Pubitemid 43005764)
31. Diehl A, Nakovics H, Croissant B, Smolka MN, Batra A, Mann K: Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial. Int J Clin Pharmacol Ther 2006;44:614-622. (Pubitemid 44896139)
32. Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Montgomery MA, Goldsmith RJ, Coleman FS, Bloch DA, Leiderman DB, Singal BM, Berger P, Elkashef A: A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction 2005;100(suppl 1):68-77. (Pubitemid 40363426)
33. Carelli RM, Deadwyler SA: A comparison of nucleus accumbens neuronal firing patterns during cocaine self-administration and water reinforcement in rats. J Neurosci 1994;14: 7735-7746. (Pubitemid 24983711)
34. Carelli RM, Ijames SG, Crumling AJ: Evidence that separate neural circuits in the nucleus accumbens encode cocaine versus 'natural' (water and food) reward. J Neurosci 2000;20:4255-4266. (Pubitemid 30365697)
35. Cachope R, Mateo Y, Mathur BN, Irving J, Wang HL, Morales M, Lovinger DM, Cheer JF: Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Rep 2012;2:33-41.
36. Threlfell S, Lalic T, Platt NJ, Jennings KA, Deisseroth K, Cragg SJ: Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron 2012;75: 58-64.
37. Surmeier DJ, Graybiel AM: A feud that wasn't: acetylcholine evokes dopamine release in the striatum. Neuron 2012;75:1-3.
38. Fritz M, El Rawas R, Salti A, Klement S, Bardo MT, Kemmler G, Dechant G, Saria A, Zernig G: Reversal of cocaine-conditioned place preference and mesocorticolimbic Zif268 expression by social interaction in rats. Addict Biol 2011;16:273-284.
39. Fritz M, Klement S, El Rawas R, Saria A, Zernig G: Sigma1 receptor antagonist BD1047 enhances reversal of conditioned place preference from cocaine to social interaction. Pharmacology 2011;87:45-48.
40. Fritz M, El Rawas R, Klement S, Kummer K, Mayr MJ, Eggart V, Salti A, Bardo MT, Saria A, Zernig G: Differential effects of accumbens core vs. shell lesion in a rat concurrent conditioned place preference paradigm for cocaine vs. social interaction. PloS One 2011; 6:e26761.
41. Kummer K, Klement S, Eggart V, Mayr MJ, Saria A, Zernig G: Conditioned place preference for social interaction in rats: contribution of sensory components. Front Behav Neurosci 2011;5:80.
42. El Rawas R, Klement S, Salti A, Fritz M, Dechant G, Saria A, Zernig G: Preventive role of social interaction for cocaine conditioned place preference: correlation with FosB/Delta- FosB and pCREB expression in rat mesocorticolimbic areas. Front Behav Neurosci 2012;6:8.
43. Paxinos G, Watson C, Carrive P, Kirkcaldie MTK, Ashwell K: Chemoarchitectonic Atlas of the Rat Brain. Amsterdam, Elsevier, 2009.
44. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. New York, Academic Press, 2007.
45. Meredith GE, Blank B, Groenewegen HJ: The distribution and compartmental organization of the cholinergic neurons in nucleus accumbens of the rat. Neuroscience 1989; 31: 327-345. (Pubitemid 19238640)
46. Kreitzer AC: Physiology and pharmacology of striatal neurons. Annu Rev Neurosci 2009; 32:127-147.
47. Zangenehpour S, Chaudhuri A: Differential induction and decay curves of c-fos and zif268 revealed through dual activity maps. Brain Res Mol Brain Res 2002;109:221-225. (Pubitemid 36078388)
48. Sezgin M, Sankur B: Survey over image thresholding techniques and quantitative performance evaluation. J Electron Imaging 2004;13:146-165.